Search Results

Costs of managing chronic disease is top of mind for employers, and the CMS's proposed legislation could have a major impact.

Hospital charges are difficult to determine, are often greatly inflated, and vary from one hospital to the next. An independent report by the RAND Corporation sheds light on the issue.

Across the U.S., CFOs, HR directors and CEOs at companies of all sizes are grappling with what to do in the face of unsustainable health insurance…

Those who purchase insurance on behalf of employers would prefer to see market forces take the lead in reshaping health care.

Negotiating fair prices from providers and lower spending for employers requires a strategy beyond reference-based pricing.

The hope is that if the health care industry can create its own satisfactory solution to price transparency, it can avert the burdensome requirements of the CMS rule.

EmployersRx is a coalition of employer groups representing more than 500 businesses advocating for prescription drug price reform.

Many in the health industry worry the rule would cause more harm than good, and just add to consumers' confusion.